Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_201f55af8da20a4706f6cc0303455503 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-00023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-00034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-00041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-812 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
filingDate |
2016-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61fc26bd83db0c63b6e7c839aec04bfe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_958b96102f60796f4d37195731adb160 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7046c341f3f25d020dfdc12306929da0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c55866fe206edff883e5806492db6bb8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28f32d6951d4d03a36283bc38ad033f4 |
publicationDate |
2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2018360935-A1 |
titleOfInvention |
COMPOSITIONS AND METHODS RELATED TO xCT PEPTIDES |
abstract |
Certain embodiments are directed to composition for inducing an immune response against xCT that is directed to cancer stem cells expressing xCT. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11059901-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020227640-A1 |
priorityDate |
2015-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |